| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging, Cine | 39 | 2022 | 934 | 5.510 |
Why?
|
| Tetralogy of Fallot | 25 | 2021 | 573 | 3.360 |
Why?
|
| Heart Ventricles | 42 | 2022 | 3835 | 2.930 |
Why?
|
| Pulmonary Valve Insufficiency | 10 | 2021 | 141 | 2.400 |
Why?
|
| Ventricular Function, Left | 26 | 2022 | 3422 | 2.280 |
Why?
|
| Pulmonary Valve | 13 | 2021 | 401 | 2.270 |
Why?
|
| Heart Defects, Congenital | 39 | 2022 | 4258 | 2.190 |
Why?
|
| Magnetic Resonance Angiography | 15 | 2021 | 1467 | 2.190 |
Why?
|
| Ventricular Function, Right | 15 | 2018 | 580 | 1.920 |
Why?
|
| Fontan Procedure | 23 | 2022 | 739 | 1.890 |
Why?
|
| Myocardial Contraction | 9 | 2019 | 1649 | 1.840 |
Why?
|
| Ventricular Dysfunction, Left | 13 | 2022 | 2033 | 1.780 |
Why?
|
| Pulmonary Artery | 18 | 2018 | 1901 | 1.400 |
Why?
|
| Ventricular Dysfunction, Right | 11 | 2018 | 576 | 1.210 |
Why?
|
| Heart | 16 | 2022 | 4326 | 1.210 |
Why?
|
| Magnetic Resonance Imaging | 64 | 2022 | 34394 | 1.190 |
Why?
|
| Stroke Volume | 33 | 2022 | 4570 | 1.190 |
Why?
|
| Imaging, Three-Dimensional | 10 | 2022 | 4010 | 1.150 |
Why?
|
| Transposition of Great Vessels | 8 | 2018 | 560 | 1.120 |
Why?
|
| Myocardium | 16 | 2022 | 4938 | 1.100 |
Why?
|
| Pulmonary Atresia | 7 | 2011 | 150 | 1.060 |
Why?
|
| Cardiac Surgical Procedures | 19 | 2020 | 3450 | 1.030 |
Why?
|
| Aortic Valve Stenosis | 7 | 2015 | 1834 | 0.960 |
Why?
|
| Ventricular Remodeling | 10 | 2018 | 1269 | 0.950 |
Why?
|
| Collateral Circulation | 4 | 2013 | 308 | 0.910 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2016 | 528 | 0.890 |
Why?
|
| Heart Valve Prosthesis Implantation | 9 | 2020 | 1487 | 0.860 |
Why?
|
| Cardiac-Gated Imaging Techniques | 3 | 2021 | 145 | 0.810 |
Why?
|
| Echocardiography, Doppler | 10 | 2018 | 960 | 0.810 |
Why?
|
| Ventricular Dysfunction | 3 | 2014 | 141 | 0.810 |
Why?
|
| Coronary Circulation | 6 | 2020 | 1652 | 0.770 |
Why?
|
| Echocardiography | 22 | 2022 | 5098 | 0.740 |
Why?
|
| Cardiac Imaging Techniques | 4 | 2021 | 268 | 0.730 |
Why?
|
| Child | 96 | 2022 | 74146 | 0.730 |
Why?
|
| Motion | 4 | 2017 | 767 | 0.720 |
Why?
|
| Predictive Value of Tests | 26 | 2022 | 15258 | 0.700 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2016 | 312 | 0.690 |
Why?
|
| Tricuspid Valve | 3 | 2018 | 394 | 0.680 |
Why?
|
| Cardiovascular System | 3 | 2022 | 767 | 0.660 |
Why?
|
| Pulmonary Circulation | 5 | 2018 | 736 | 0.650 |
Why?
|
| Ebstein Anomaly | 1 | 2018 | 93 | 0.640 |
Why?
|
| Adolescent | 91 | 2022 | 84999 | 0.640 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2021 | 3421 | 0.620 |
Why?
|
| Recovery of Function | 9 | 2020 | 2950 | 0.610 |
Why?
|
| Coronary Vessels | 6 | 2016 | 2970 | 0.610 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2022 | 8998 | 0.610 |
Why?
|
| Respiration | 4 | 2022 | 1670 | 0.600 |
Why?
|
| Iron Overload | 3 | 2021 | 233 | 0.600 |
Why?
|
| Child, Preschool | 64 | 2022 | 41181 | 0.590 |
Why?
|
| Sodium Channels | 11 | 2010 | 374 | 0.590 |
Why?
|
| Diaphragm | 2 | 2017 | 355 | 0.580 |
Why?
|
| Exercise Tolerance | 8 | 2019 | 798 | 0.570 |
Why?
|
| Ventricular Pressure | 2 | 2015 | 217 | 0.560 |
Why?
|
| Aortic Coarctation | 4 | 2015 | 266 | 0.560 |
Why?
|
| Endocardial Cushion Defects | 1 | 2014 | 46 | 0.540 |
Why?
|
| Diastole | 8 | 2022 | 830 | 0.540 |
Why?
|
| Young Adult | 53 | 2022 | 56155 | 0.520 |
Why?
|
| Contrast Media | 14 | 2020 | 5270 | 0.520 |
Why?
|
| Leukemia | 1 | 2022 | 1524 | 0.510 |
Why?
|
| Infant | 52 | 2022 | 34497 | 0.510 |
Why?
|
| Retrospective Studies | 61 | 2022 | 72255 | 0.500 |
Why?
|
| Myocarditis | 2 | 2021 | 680 | 0.500 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2014 | 71 | 0.490 |
Why?
|
| Iron | 4 | 2021 | 1735 | 0.480 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 2018 | 183 | 0.470 |
Why?
|
| Health Resources | 2 | 2017 | 924 | 0.460 |
Why?
|
| Heart Diseases | 5 | 2021 | 2763 | 0.460 |
Why?
|
| Humans | 178 | 2022 | 715124 | 0.450 |
Why?
|
| Iron Chelating Agents | 2 | 2014 | 143 | 0.440 |
Why?
|
| Aorta | 9 | 2016 | 2118 | 0.440 |
Why?
|
| Catheterization | 4 | 2010 | 1453 | 0.430 |
Why?
|
| Adult | 82 | 2022 | 212129 | 0.430 |
Why?
|
| Hemosiderosis | 1 | 2012 | 71 | 0.430 |
Why?
|
| Reproducibility of Results | 25 | 2022 | 19499 | 0.430 |
Why?
|
| Heart Neoplasms | 4 | 2011 | 383 | 0.420 |
Why?
|
| Angiography | 4 | 2020 | 1668 | 0.420 |
Why?
|
| Thalassemia | 2 | 2008 | 267 | 0.420 |
Why?
|
| Observer Variation | 12 | 2018 | 2680 | 0.410 |
Why?
|
| Male | 112 | 2022 | 351081 | 0.410 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 1729 | 0.400 |
Why?
|
| Postoperative Care | 1 | 2017 | 1512 | 0.390 |
Why?
|
| Blood Flow Velocity | 7 | 2012 | 1444 | 0.390 |
Why?
|
| Exercise | 3 | 2022 | 5319 | 0.390 |
Why?
|
| Aorta, Thoracic | 6 | 2015 | 1038 | 0.390 |
Why?
|
| Female | 107 | 2022 | 377334 | 0.380 |
Why?
|
| Gadolinium DTPA | 6 | 2016 | 829 | 0.380 |
Why?
|
| Health Promotion | 1 | 2022 | 2180 | 0.370 |
Why?
|
| Heart Bypass, Right | 1 | 2009 | 77 | 0.360 |
Why?
|
| Phantoms, Imaging | 7 | 2022 | 2412 | 0.360 |
Why?
|
| Dobutamine | 1 | 2009 | 127 | 0.350 |
Why?
|
| Artifacts | 2 | 2015 | 1906 | 0.350 |
Why?
|
| Algorithms | 13 | 2021 | 13669 | 0.330 |
Why?
|
| Fibrosis | 6 | 2018 | 1944 | 0.330 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2013 | 1188 | 0.320 |
Why?
|
| Image Enhancement | 4 | 2014 | 2978 | 0.320 |
Why?
|
| Propanolamines | 1 | 2007 | 167 | 0.310 |
Why?
|
| Time Factors | 25 | 2020 | 41081 | 0.310 |
Why?
|
| Systole | 5 | 2017 | 993 | 0.310 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 14326 | 0.300 |
Why?
|
| Heart Septum | 1 | 2007 | 321 | 0.300 |
Why?
|
| Exercise Test | 12 | 2018 | 2116 | 0.300 |
Why?
|
| Electrophysiology | 2 | 2009 | 1331 | 0.300 |
Why?
|
| Ion Channels | 2 | 2009 | 1082 | 0.290 |
Why?
|
| Carbazoles | 1 | 2007 | 238 | 0.290 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1829 | 0.290 |
Why?
|
| Heart Rate | 3 | 2021 | 4102 | 0.280 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2018 | 121 | 0.280 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 551 | 0.280 |
Why?
|
| Diseases in Twins | 1 | 2007 | 463 | 0.270 |
Why?
|
| Muscular Dystrophies | 1 | 2007 | 390 | 0.270 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2018 | 553 | 0.270 |
Why?
|
| Biomedical Research | 1 | 2020 | 3273 | 0.270 |
Why?
|
| Ion Channel Gating | 7 | 2012 | 455 | 0.260 |
Why?
|
| Treatment Outcome | 33 | 2020 | 62186 | 0.260 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2016 | 861 | 0.260 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2011 | 488 | 0.260 |
Why?
|
| Health Care Costs | 1 | 2017 | 3171 | 0.240 |
Why?
|
| Tachycardia, Ventricular | 5 | 2018 | 1214 | 0.240 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 2129 | 0.240 |
Why?
|
| Follow-Up Studies | 27 | 2021 | 39285 | 0.240 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2015 | 210 | 0.230 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2006 | 480 | 0.230 |
Why?
|
| Ganglia, Spinal | 6 | 2010 | 510 | 0.230 |
Why?
|
| Ventricular Function | 4 | 2020 | 423 | 0.230 |
Why?
|
| Pulsatile Flow | 2 | 2002 | 334 | 0.230 |
Why?
|
| Cardiology | 3 | 2020 | 1651 | 0.230 |
Why?
|
| Quality Improvement | 2 | 2017 | 3748 | 0.220 |
Why?
|
| Heart Transplantation | 7 | 2021 | 3081 | 0.220 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2001 | 47 | 0.220 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 1230 | 0.210 |
Why?
|
| Infant, Newborn | 23 | 2016 | 24645 | 0.210 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 816 | 0.210 |
Why?
|
| Hemangioma | 2 | 2011 | 738 | 0.210 |
Why?
|
| Respiratory Mechanics | 2 | 2016 | 642 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 3 | 2020 | 1495 | 0.210 |
Why?
|
| Vascular Fistula | 1 | 2000 | 53 | 0.200 |
Why?
|
| Drug Discovery | 1 | 2009 | 1067 | 0.200 |
Why?
|
| Oximetry | 1 | 2003 | 466 | 0.190 |
Why?
|
| Echocardiography, Doppler, Pulsed | 2 | 2011 | 74 | 0.190 |
Why?
|
| Abnormalities, Multiple | 3 | 2011 | 1385 | 0.190 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2020 | 272 | 0.190 |
Why?
|
| Anemia | 1 | 2008 | 1416 | 0.180 |
Why?
|
| Coronary Aneurysm | 1 | 2002 | 223 | 0.180 |
Why?
|
| Patch-Clamp Techniques | 7 | 2014 | 979 | 0.180 |
Why?
|
| Hemodynamics | 7 | 2018 | 4226 | 0.180 |
Why?
|
| Middle Aged | 36 | 2020 | 214871 | 0.180 |
Why?
|
| Cardiac Volume | 2 | 2010 | 212 | 0.180 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2014 | 592 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2022 | 3705 | 0.170 |
Why?
|
| Stents | 5 | 2015 | 3303 | 0.170 |
Why?
|
| Cell Line | 9 | 2009 | 16680 | 0.170 |
Why?
|
| ROC Curve | 4 | 2018 | 3526 | 0.170 |
Why?
|
| Neurons, Afferent | 4 | 2005 | 518 | 0.170 |
Why?
|
| Models, Cardiovascular | 2 | 2012 | 1004 | 0.170 |
Why?
|
| Fibroma | 3 | 2011 | 214 | 0.170 |
Why?
|
| Gadolinium | 4 | 2009 | 910 | 0.170 |
Why?
|
| Sensitivity and Specificity | 7 | 2022 | 14877 | 0.160 |
Why?
|
| Protein Subunits | 4 | 2012 | 1017 | 0.160 |
Why?
|
| Bioprosthesis | 2 | 2020 | 613 | 0.160 |
Why?
|
| Prospective Studies | 18 | 2022 | 51181 | 0.160 |
Why?
|
| Diskectomy | 1 | 2018 | 196 | 0.150 |
Why?
|
| Fetal Heart | 1 | 2018 | 274 | 0.150 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2016 | 63 | 0.150 |
Why?
|
| Regional Blood Flow | 4 | 2012 | 1568 | 0.150 |
Why?
|
| Protons | 1 | 2021 | 1068 | 0.150 |
Why?
|
| Boston | 10 | 2021 | 9400 | 0.150 |
Why?
|
| Databases, Factual | 6 | 2018 | 7836 | 0.150 |
Why?
|
| Pulmonary Veins | 3 | 2011 | 716 | 0.150 |
Why?
|
| Behavior Therapy | 1 | 2022 | 869 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 616 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2018 | 1595 | 0.140 |
Why?
|
| Poisson Distribution | 1 | 2017 | 515 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2020 | 777 | 0.140 |
Why?
|
| Liver | 3 | 2021 | 7647 | 0.140 |
Why?
|
| Oxygen Consumption | 6 | 2019 | 1933 | 0.140 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 713 | 0.140 |
Why?
|
| Risk Factors | 20 | 2020 | 70704 | 0.140 |
Why?
|
| Cross-Sectional Studies | 11 | 2022 | 23283 | 0.140 |
Why?
|
| Marijuana Smoking | 1 | 2018 | 252 | 0.130 |
Why?
|
| Heart Failure | 5 | 2022 | 10123 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 2 | 2015 | 1478 | 0.130 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2014 | 15 | 0.130 |
Why?
|
| Coronary Angiography | 4 | 2018 | 4401 | 0.130 |
Why?
|
| Radiation Protection | 1 | 2018 | 456 | 0.130 |
Why?
|
| Pichia | 1 | 2014 | 54 | 0.130 |
Why?
|
| Radiography | 7 | 2013 | 6994 | 0.130 |
Why?
|
| Heart Septal Defects | 1 | 2014 | 179 | 0.120 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2010 | 599 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 5 | 2010 | 4595 | 0.120 |
Why?
|
| Elasticity | 1 | 2015 | 658 | 0.120 |
Why?
|
| Hospitals, Pediatric | 4 | 2018 | 1780 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2014 | 1408 | 0.120 |
Why?
|
| Aequorin | 1 | 2012 | 16 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 961 | 0.120 |
Why?
|
| Feasibility Studies | 5 | 2020 | 4916 | 0.120 |
Why?
|
| Arteries | 1 | 2018 | 1106 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1995 | 525 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 7480 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2016 | 457 | 0.110 |
Why?
|
| Bundle-Branch Block | 1 | 2014 | 276 | 0.110 |
Why?
|
| Postoperative Complications | 6 | 2017 | 15098 | 0.110 |
Why?
|
| Electrocardiography | 9 | 2021 | 6403 | 0.110 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2016 | 576 | 0.110 |
Why?
|
| Aged | 16 | 2022 | 162674 | 0.110 |
Why?
|
| beta-Thalassemia | 1 | 2014 | 239 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3158 | 0.110 |
Why?
|
| Connexin 43 | 1 | 2012 | 217 | 0.110 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3276 | 0.110 |
Why?
|
| Organ Size | 6 | 2015 | 2313 | 0.110 |
Why?
|
| Ventricular Septum | 1 | 2011 | 54 | 0.110 |
Why?
|
| Prognosis | 9 | 2015 | 29168 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 2 | 2014 | 932 | 0.100 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 339 | 0.100 |
Why?
|
| Nicotinic Antagonists | 1 | 2011 | 95 | 0.100 |
Why?
|
| Fetal Diseases | 2 | 2007 | 898 | 0.100 |
Why?
|
| Cicatrix | 1 | 2016 | 693 | 0.100 |
Why?
|
| Membrane Potentials | 7 | 2014 | 1184 | 0.100 |
Why?
|
| Registries | 4 | 2018 | 8090 | 0.100 |
Why?
|
| Vena Cava, Inferior | 2 | 2011 | 449 | 0.100 |
Why?
|
| Disease Progression | 5 | 2016 | 13302 | 0.100 |
Why?
|
| Knee Injuries | 1 | 2015 | 472 | 0.100 |
Why?
|
| Sarcomeres | 1 | 2013 | 353 | 0.100 |
Why?
|
| Pandemics | 2 | 2020 | 7213 | 0.100 |
Why?
|
| Computer Simulation | 2 | 2022 | 6075 | 0.100 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2010 | 43 | 0.100 |
Why?
|
| Blood Pressure | 5 | 2015 | 8566 | 0.100 |
Why?
|
| Program Evaluation | 2 | 2017 | 2529 | 0.100 |
Why?
|
| Linear Models | 5 | 2016 | 5980 | 0.100 |
Why?
|
| Brachiocephalic Trunk | 1 | 2009 | 39 | 0.090 |
Why?
|
| Multivariate Analysis | 8 | 2018 | 12477 | 0.090 |
Why?
|
| Hospitalization | 2 | 2021 | 9718 | 0.090 |
Why?
|
| Public Health | 1 | 2022 | 2374 | 0.090 |
Why?
|
| Reference Values | 3 | 2022 | 5061 | 0.090 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2008 | 29 | 0.090 |
Why?
|
| Biological Assay | 1 | 2012 | 658 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 1839 | 0.090 |
Why?
|
| Arthroscopy | 1 | 2015 | 842 | 0.090 |
Why?
|
| Ectopia Cordis | 1 | 2008 | 6 | 0.090 |
Why?
|
| Palliative Care | 3 | 2013 | 3289 | 0.090 |
Why?
|
| Equipment Design | 4 | 2018 | 3628 | 0.080 |
Why?
|
| Rhabdomyoma | 2 | 2011 | 54 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1709 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 491 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2012 | 764 | 0.080 |
Why?
|
| Area Under Curve | 3 | 2018 | 1693 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 6858 | 0.080 |
Why?
|
| Electrophysiological Phenomena | 1 | 2009 | 313 | 0.080 |
Why?
|
| Locomotion | 1 | 1989 | 377 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 160 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 574 | 0.080 |
Why?
|
| Heart Aneurysm | 1 | 2007 | 123 | 0.080 |
Why?
|
| Patient Care Management | 1 | 2010 | 319 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 7051 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 1989 | 296 | 0.080 |
Why?
|
| Heart Atria | 3 | 2018 | 1273 | 0.070 |
Why?
|
| Critical Pathways | 1 | 2010 | 459 | 0.070 |
Why?
|
| Canada | 3 | 2020 | 1947 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2012 | 936 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2014 | 1458 | 0.070 |
Why?
|
| Vascular Resistance | 1 | 2009 | 958 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2534 | 0.070 |
Why?
|
| Survival Rate | 4 | 2018 | 13255 | 0.070 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2005 | 50 | 0.070 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2005 | 33 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1383 | 0.070 |
Why?
|
| Risk Assessment | 8 | 2018 | 23511 | 0.070 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2005 | 32 | 0.070 |
Why?
|
| Teratoma | 2 | 2011 | 388 | 0.070 |
Why?
|
| Neuropeptides | 2 | 2001 | 933 | 0.070 |
Why?
|
| United States | 9 | 2021 | 67665 | 0.070 |
Why?
|
| Age Factors | 4 | 2019 | 18789 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2012 | 1057 | 0.070 |
Why?
|
| Receptors, GABA-A | 1 | 2009 | 623 | 0.070 |
Why?
|
| Patient Selection | 1 | 2017 | 4320 | 0.070 |
Why?
|
| Prenatal Diagnosis | 2 | 2010 | 1162 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2012 | 1502 | 0.060 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 16011 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 9561 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2016 | 9968 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 11285 | 0.060 |
Why?
|
| Tetrodotoxin | 2 | 2002 | 257 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2010 | 983 | 0.060 |
Why?
|
| Capsaicin | 1 | 2004 | 239 | 0.060 |
Why?
|
| Software | 1 | 2017 | 4350 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6779 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2008 | 1757 | 0.060 |
Why?
|
| Transducers | 2 | 2018 | 247 | 0.060 |
Why?
|
| Logistic Models | 5 | 2018 | 13594 | 0.060 |
Why?
|
| Cohort Studies | 8 | 2022 | 39804 | 0.060 |
Why?
|
| Hemangioma, Capillary | 1 | 2002 | 60 | 0.060 |
Why?
|
| Neuralgia | 2 | 2005 | 520 | 0.060 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 1960 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2020 | 2144 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 6137 | 0.050 |
Why?
|
| Postoperative Period | 3 | 2012 | 1854 | 0.050 |
Why?
|
| Dilatation, Pathologic | 2 | 2016 | 516 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 2189 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2012 | 2333 | 0.050 |
Why?
|
| Polyvinyls | 1 | 2002 | 162 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2003 | 242 | 0.050 |
Why?
|
| Coronary Stenosis | 2 | 2008 | 810 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2007 | 1102 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2014 | 21790 | 0.050 |
Why?
|
| Metals | 1 | 2005 | 691 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 317 | 0.050 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 11402 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2010 | 1851 | 0.050 |
Why?
|
| Transfection | 5 | 2008 | 6143 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 514 | 0.050 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 946 | 0.050 |
Why?
|
| Equipment Failure | 2 | 2006 | 582 | 0.050 |
Why?
|
| Animals | 12 | 2020 | 170726 | 0.050 |
Why?
|
| Calcium | 1 | 2012 | 5818 | 0.040 |
Why?
|
| HEK293 Cells | 3 | 2014 | 4321 | 0.040 |
Why?
|
| Rats | 7 | 2014 | 25090 | 0.040 |
Why?
|
| Sheep | 2 | 2013 | 1469 | 0.040 |
Why?
|
| Medical Records | 1 | 2004 | 1420 | 0.040 |
Why?
|
| Aortography | 1 | 2000 | 438 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2002 | 1017 | 0.040 |
Why?
|
| Troponin | 1 | 2021 | 507 | 0.040 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 75 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 721 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 750 | 0.040 |
Why?
|
| Anesthesia | 1 | 2008 | 1515 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 1343 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2000 | 906 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 257 | 0.040 |
Why?
|
| Ohio | 1 | 2017 | 344 | 0.040 |
Why?
|
| Kentucky | 1 | 2016 | 78 | 0.040 |
Why?
|
| Ontario | 1 | 2017 | 363 | 0.040 |
Why?
|
| Length of Stay | 3 | 2021 | 6278 | 0.040 |
Why?
|
| Troponin T | 1 | 2022 | 752 | 0.040 |
Why?
|
| Radiographic Image Enhancement | 1 | 2002 | 921 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 14237 | 0.040 |
Why?
|
| Electric Stimulation | 3 | 2008 | 1778 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2406 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1174 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 1902 | 0.040 |
Why?
|
| Probability | 1 | 2001 | 2480 | 0.040 |
Why?
|
| Europe | 2 | 2013 | 3345 | 0.040 |
Why?
|
| American Heart Association | 1 | 2020 | 985 | 0.040 |
Why?
|
| Germany | 1 | 2018 | 825 | 0.040 |
Why?
|
| Stainless Steel | 1 | 2015 | 85 | 0.040 |
Why?
|
| Scotland | 1 | 2015 | 152 | 0.040 |
Why?
|
| Hypertension | 1 | 2015 | 8247 | 0.040 |
Why?
|
| Incidence | 5 | 2015 | 20596 | 0.030 |
Why?
|
| Sweden | 1 | 2018 | 1318 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3489 | 0.030 |
Why?
|
| Aftercare | 1 | 2020 | 705 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2011 | 8602 | 0.030 |
Why?
|
| Norwood Procedures | 1 | 2016 | 160 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2018 | 645 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2015 | 334 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2001 | 1187 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 1225 | 0.030 |
Why?
|
| Rupture | 1 | 2015 | 428 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 2101 | 0.030 |
Why?
|
| Survivors | 1 | 2004 | 2165 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2022 | 1575 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2014 | 4483 | 0.030 |
Why?
|
| Flow Injection Analysis | 1 | 2012 | 22 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2003 | 6480 | 0.030 |
Why?
|
| Luminescent Agents | 1 | 2012 | 32 | 0.030 |
Why?
|
| Cerebellum | 1 | 2000 | 1491 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 562 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 2678 | 0.030 |
Why?
|
| Comorbidity | 1 | 2007 | 10423 | 0.030 |
Why?
|
| Infection Control | 1 | 2020 | 955 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6531 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 18734 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2001 | 1422 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 986 | 0.030 |
Why?
|
| Nocardia | 1 | 1991 | 11 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2000 | 1566 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2020 | 20398 | 0.030 |
Why?
|
| Pregnancy | 3 | 2008 | 27180 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2744 | 0.030 |
Why?
|
| Binding Sites | 2 | 2012 | 6289 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2012 | 5535 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2015 | 801 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 293 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 1705 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 2085 | 0.030 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 462 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2018 | 1823 | 0.030 |
Why?
|
| Disulfides | 1 | 2012 | 462 | 0.030 |
Why?
|
| Codon | 1 | 2012 | 615 | 0.030 |
Why?
|
| Angioplasty, Balloon | 1 | 2015 | 730 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2010 | 351 | 0.020 |
Why?
|
| CHO Cells | 2 | 2004 | 1442 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 510 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 872 | 0.020 |
Why?
|
| Flumazenil | 1 | 2009 | 83 | 0.020 |
Why?
|
| Echocardiography, Stress | 1 | 2010 | 133 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2009 | 62 | 0.020 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2009 | 85 | 0.020 |
Why?
|
| Gestational Age | 1 | 2018 | 3414 | 0.020 |
Why?
|
| Cricetinae | 2 | 2004 | 2595 | 0.020 |
Why?
|
| Physical Examination | 1 | 2015 | 1243 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2018 | 2038 | 0.020 |
Why?
|
| Receptors, Purinergic P2X2 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3565 | 0.020 |
Why?
|
| Radiation | 1 | 2008 | 52 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2022 | 5155 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2008 | 129 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58505 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 2001 | 1172 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 737 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 12425 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2014 | 1032 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4353 | 0.020 |
Why?
|
| Azides | 1 | 2008 | 131 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2013 | 2363 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 462 | 0.020 |
Why?
|
| Cardiology Service, Hospital | 1 | 2010 | 254 | 0.020 |
Why?
|
| Coronary Disease | 2 | 2002 | 6123 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2020 | 3769 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2018 | 3509 | 0.020 |
Why?
|